echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Fda authorizes first home COVID-19 and influenza combination tests to collect samples

    Fda authorizes first home COVID-19 and influenza combination tests to collect samples

    • Last Update: 2021-03-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    , the U.S. Food and Drug Administration approved the first diagnostic test for taking patient samples at home to test
    COVID-19
    influenza A and B.
    FDA
    Authorized
    Quest Diagnostics RC COVID-19 and Flu RT-PCR
    Testing with
    Quest Diagnostics
    Self-Collection Kit
    prescriptions for coVID-19 plus
    influenza, collected and used at home by individual patients suspected of respiratory virus infections and in accordance with
    COVID-19
    , are appropriate at the decision of the healthcare provider. On the orders of health care providers, patients can collect samples at home and ship them to the
    Quest Diagnostics laboratory for analysis as described
    the self-collection kit.“ The recent authorization of home-collected samples for
    COVID-19
    plus the use of influenza testing is an important step in the
    FDA
    's nationwide response to
    COVID-19
    . With the test's mandate, the
    FDA
    is helping to deal with the ongoing fight against
    COVID-19
    in the middle of the flu season, which is important for many people, including the most vulnerable Americans. This is another example of
    FDA
    working with test developers to bring important diagnoses to Americans," said
    dr. stephen M. Hahn
    ,
    FDA
    Commissioner. In a comfortable and relatively safe home, it provides Americans with answers faster, allowing patients to remain isolated and wait for results. This efficiency can go a long way to providing timely information to patients with unknown respiratory diseases. (
    cyy123.com
    )original source:
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.